Study Suggests Risperidone Long-Acting Injection Combined With Standard Treatment Helped Delay Time To Relapse In Patients With Bipolar Disorder
Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those who received standard treatment combined with placebo.
Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression, And Seroquel R For The Treatment Of Bipolar Depression
AstraZeneca announced that the company has submitted applications in the European Union (EU) under the Mutual Recognition Procedure (MRP) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, seeking approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.
Bipolar Depression Licence Application For Seroquel R
AstraZeneca has submitted an application to the Medicines and Healthcare products Regulatory Agency (MHRA) for a new licence for Seroquel(R) (quetiapine fumarate) in the UK for major depressive episodes in the framework of bipolar disorder. Quetiapine is currently licensed in the UK for the treatment of schizophrenia and manic episodes associated with bipolar disorder.
Alexza Initiates First Phase 3 Clinical Trial For AZ-004 Staccato R Loxapine
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated its first Phase 3 clinical trial with AZ-004 (Staccato(R) loxapine). AZ-004 is an inhalation product candidate being developed for the treatment of acute agitation in patients with schizophrenia or bipolar disorder.
Indiana U Study May Alter Approach To Psychiatric Treatment
Indiana University School of Medicine researchers have isolated biomarkers in the blood that identify mood disorders, a breakthrough that may change the way bipolar illness is diagnosed and treated. The report will be published in the February 26 advance online edition of the journal Molecular Psychiatry.
ABILIFY Approved For Acute Treatment Of Bipolar I Disorder In Patients 10 To 17 Years Old
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
Breast Cancer Drug Tamoxifen May Decrease Mania Of Bipolar Disorder
The drug tamoxifen is usually used to treat breast cancer, butresearchers say that it also may reduce symptoms of mania in peoplewith bipolar disorder. An article summarizing the small, three-weektrial of tamoxifen is published in Archives of GeneralPsychiatry.
New Clues For Uncovering The Mysteries Of Mental Illness
Scientists have discovered epigenetic changes (i.e. chemical changes to a gene that do not alter the DNA sequence) in individuals with schizophrenia and bipolar disorder. This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step on the journey to fully understanding major psychosis.
New Mouse Model Of Bipolar Disorder
Bipolar Disorder (BPD or manic-depressive illness) is one of the most serious of all mental disorders, affecting millions of individuals worldwide. Affected individuals alternate between states of deep depression and mania. While depression is characterized by persistent and long-term sadness or despair, mania is a mental state characterized by great excitement, flight of ideas, a decreased need for sleep, and, sometimes, uncontrollable behavior, hallucinations, or delusions.
Famous Bipolar People Contest Raises Awareness, Encourages Research
Famous bipolar people include some of the world's foremost musicians, actors, writers, composers and scientists. A new contest launched on YouTube uses the current interest in bipolar celebrities to raise awareness about bipolar disorder. The Famous Bipolar People Contest encourages research and reflection.